Is gabapentin (Neurontin) safe during breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin Safety During Breastfeeding

Gabapentin can be used during breastfeeding with minimal risk to the infant, as it transfers into breast milk in small amounts with a relative infant dose well below the safety threshold of 10%. 1

Transfer into Breast Milk and Infant Exposure

  • Gabapentin is secreted into human milk following oral administration
  • A breastfed infant could be exposed to a maximum dose of approximately 1 mg/kg/day of gabapentin 2
  • The milk-to-plasma ratio is less than 1, indicating limited transfer into breast milk 1
  • The relative infant dose (RID) is below 10%, which is considered the safety threshold for most medications during breastfeeding 1, 3

Clinical Recommendations

When to Use Gabapentin While Breastfeeding

  • Gabapentin can be used when treating:
    • Postherpetic neuralgia
    • Epilepsy/seizure disorders
    • Neuropathic pain conditions
    • Other off-label indications when benefits outweigh risks

Monitoring Recommendations

  • Monitor the breastfed infant for:
    • Drowsiness
    • Poor feeding
    • Irritability
    • Changes in sleep patterns
  • If any concerning symptoms develop, contact a healthcare provider 2

Dosing Considerations

  • Consider timing doses to minimize infant exposure:
    • Take medication immediately after breastfeeding
    • Take medication before the infant's longest sleep period 4, 5
  • Use the lowest effective dose that adequately treats the mother's condition

Special Considerations

Concurrent Opioid Use

  • Extra caution is warranted when gabapentin is used concurrently with opioids
  • This combination may increase the risk of sedation in both mother and infant 6
  • More careful monitoring of the infant is recommended in these situations

Premature or Medically Compromised Infants

  • Use with additional caution in mothers of premature infants or those with impaired renal function
  • These infants may have reduced ability to metabolize and excrete medications

Alternative Medications

  • If concerns exist about gabapentin use during breastfeeding, consider:
    • Local anesthetics for pain management (compatible with breastfeeding) 7
    • Non-pharmacological pain management approaches
    • Other antiepileptic medications with established safety profiles during lactation

Common Pitfalls to Avoid

  1. Unnecessarily discontinuing breastfeeding: The benefits of breastfeeding generally outweigh the minimal risks of gabapentin exposure through breast milk
  2. Inadequate maternal treatment: Undertreating the mother's condition due to breastfeeding concerns can negatively impact both mother and infant
  3. Lack of monitoring: Failing to monitor the infant for potential adverse effects
  4. Not consulting reliable resources: Using outdated information about medication safety in breastfeeding

In conclusion, while the FDA label states that gabapentin "should be used in women who are nursing only if the benefits clearly outweigh the risks" 2, current clinical evidence suggests that gabapentin is generally compatible with breastfeeding with appropriate monitoring and precautions.

References

Research

Antiepileptic drugs and breastfeeding.

Italian journal of pediatrics, 2013

Research

Benzodiazepine Concentrations in the Breast Milk and Plasma of Nursing Mothers: Estimation of Relative Infant Dose.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2021

Research

Medication Safety in Breastfeeding.

American family physician, 2022

Research

Medications in pregnancy and lactation.

Emergency medicine clinics of North America, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.